A new liquid chromatography/tandem mass spectrometry method for quantification of gangliosides in human plasma

Analytical Biochemistry

Volumn 455, Issue 1, 2014, Pages 26-34

  Huang, Qianyang ^a   Zhou, Xiang ^a   Liu, Danting ^a   Xin, Baozhong ^b   Cechner, Karen ^b   Wang, Heng ^b   Zhou, Aimin ^a  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b Center for Special Needs Children   (United States)

Author keywords

Gangliosides; GM3 synthase deficiency; Mass spectrometry; Neurological disorders

Indexed keywords

CALIBRATION; ELECTROSPRAY IONIZATION; LIQUIDS; MASS SPECTROMETRY; NEUROLOGY; PLASMA (HUMAN);

GANGLIOSIDES; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MULTIPLE-REACTION MONITORING MODES; NEUROLOGICAL DISORDERS; REVERSE PHASE LIQUID CHROMATOGRAPHY; STANDARD ADDITION CALIBRATION; SYNTHASES; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

GANGLIOSIDE GD2; GANGLIOSIDE GD3; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GANGLIOSIDE; GANGLIOSIDE, GD2; GANGLIOSIDE, GD3; SIALYLTRANSFERASE;

ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; HUMAN; MEASUREMENT ACCURACY; MULTIPLE REACTION MONITORING MODE; PLASMA; PRECIPITATION; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; BLOOD; CARBOHYDRATE ANALYSIS; CASE CONTROL STUDY; DEFICIENCY; EPILEPSY; FEMALE; GM2 GANGLIOSIDOSIS; LIQUID CHROMATOGRAPHY; MALE; MOLECULAR GENETICS; PROCEDURES; REPRODUCIBILITY;

CALIBRATION; CARBOHYDRATE SEQUENCE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; EPILEPSY; FEMALE; G(M3) GANGLIOSIDE; GANGLIOSIDES; GANGLIOSIDOSES, GM2; HUMANS; MALE; MOLECULAR SEQUENCE DATA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIALYLTRANSFERASES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84899104729     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2014.03.014     Document Type: Article

References (40)

1. R.K. Yu, Y. Nakatani, and M. Yanagisawa The role of glycosphingolipid metabolism in the developing brain J. Lipid Res. 50 2009 S440 S445
2. L. Svennerholm The gangliosides J. Lipid Res. 5 1964 145 155
3. R.K. Yu, Y. Tsai, and T. Ariga Functional roles of gangliosides in neurodevelopment: an overview of recent advances Neurochem. Res. 37 2012 1230 1244
4. K. Furukawa, Y. Ohmi, Y. Ohkawa, N. Tokuda, Y. Kondo, O. Tajima, and K. Furukawa Regulatory mechanisms of nervous systems with glycosphingolipids Neurochem. Res. 36 2011 1578 1586
5. S. Hakomori, K. Handa, K. Iwabuchi, S. Yamamura, and A. Prinetti New insights in glycosphingolipid function: "Glycosignaling domain", a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling Glycobiology 8 1998 xi xix
6. C.B. Zeller, and R.B. Marchase Gangliosides as modulators of cell function Am. J. Physiol. 262 1992 C1341 C1355
7. T. Kolter, F. Winau, U.E. Schaible, M. Leippe, and K. Sandhoff Lipid-binding proteins in membrane digestion, antigen presentation, and antimicrobial defense J. Biol. Chem. 280 2005 41125 41128 (Pubitemid 41832164)
8. T. Ariga, W.D. Jarvis, and R.K. Yu Role of sphingolipid-mediated cell death in neurodegenerative diseases J. Lipid Res. 39 1998 1 16 (Pubitemid 28063538)
9. R.G.W. Anderson The caveolae membrane system Annu. Rev. Biochem. 67 1998 199 225 (Pubitemid 28411129)
10. K. Simons, and R. Ehehalt Cholesterol, lipid rafts, and disease J. Clin. Invest. 110 2002 597 603 (Pubitemid 34988781)
11. M.A. Simpson, H. Cross, C. Proukakis, D.A. Priestman, D.C. Neville, and G. Reinkensmeier et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase Nat. Genet. 36 2004 1225 1229 (Pubitemid 41288973)
12. F. Farukhi, C. Dakkouri, H. Wang, M. Wiztnitzer, and E. Traboulsi Etiology of vision loss in ganglioside GM3 synthase deficiency Ophthalmic Genet. 27 2006 89 91 (Pubitemid 44527215)
13. Y. Kacher, and A.H. Futerman Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options FEBS Lett. 580 2006 5510 5517 (Pubitemid 44465909)
14. D.J. Mahuran Biochemical consequences of mutations causing the GM2 gangliosidoses Biochim. Biophys. Acta 1455 1999 105 138 (Pubitemid 29435983)
15. G.H.B. Maegawa, T. Stockley, M. Tropak, B. Banwell, S. Blaser, F. Kok, R. Giugliani, D. Mahuran, and J.T. Clarke The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported Pediatrics 118 2006 e1550 e1562
16. T. Itakura, A. Kuroki, Y. Ishibashi, D. Tsuji, E. Kawashita, Y. Higashine, H. Sakuraba, S. Yamanaka, and K. Itoh Inefficiency in GM2 ganglioside elimination by human lysosomal β-hexosaminidase β-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice Biol. Pharm. Bull. 29 2006 1564 1569 (Pubitemid 44166352)
17. D.R. Martin, N.R. Cox, N.E. Morrison, D.M. Kennamer, S.L. Peck, and A.N. Dodson et al. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis Acta Neuropathol. 110 2005 443 450 (Pubitemid 41672337)
18. P. Cordeiro, P. Hechtman, and F. Kaplan The GM2 gangliosidoses databases: allelic variation at the HEXA, HEXB, and GM2A gene loci Genet. Med. 2 2000 319 327 (Pubitemid 32045709)
19. E.A. Fazzini The Effect of Gangliosides on a Neurotoxin (MPTP) Induced Model of Parkinson's Disease in Mice 1989 Boston University Boston p. 175
20. E. Di Pasquale, J. Fantini, H. Chahinian, M. Maresca, N. Taïeb, and N. Yahi Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of α-synuclein is corrected by GM3 but not by GM1 gangliosides J. Mol. Biol. 397 2010 202 218
21. T. Ariga, M.P. McDonald, and R.K. Yu Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease - a review J. Lipid Res. 49 2008 1157 1175
22. F. Majer, L. Trnka, L. Vítek, M. Jirkovská, Z. Marecek, and F. Smíd Estrogen-induced cholestasis results in a dramatic increase of b-series gangliosides in the rat liver Biomed. Chromatogr. 21 2007 446 450 (Pubitemid 46736177)
23. B. Kniep, and P.F. Muehlradt Immunochemical detection of glycosphingolipids on thin-layer chromatograms Anal. Biochem. 188 1990 5 8 (Pubitemid 20215866)
24. E.M. Kaye, M.D. Ullman, E.H. Kolodny, W. Krivit, and J.C. Rischert Possible use of CSF glycosphingolipids for the diagnosis and therapeutic monitoring of lysosomal storage diseases Neurology 42 1992 2290 2294 (Pubitemid 23001589)
25. M.D. Ullman, and R.H. McCluer Quantitative analysis of brain gangliosides by high performance liquid chromatography of their perbenzoyl derivatives J. Lipid Res. 26 1985 501 506 (Pubitemid 15099376)
26. J. Kuei, G.R. Her, and V.N. Reinhold Supercritical fluid chromatography of glycosphingolipids Anal. Biochem. 172 1988 228 234
27. D. Tsuji, Y. Higashine, K. Matsuoka, H. Sakuraba, and K. Itoh Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies Clin. Chim. Acta 378 2007 38 41 (Pubitemid 46241058)
28. J. Gu, C.J. Tifft, and S.J. Soldin Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry Clin. Biochem. 41 2008 413 417
29. L.K. Sørensen A liquid chromatography/tandem mass spectrometric approach for the determination of gangliosides GD3 and GM3 in bovine milk and infant formulae Rapid Commun. Mass Spectrom. 20 2006 3625 3633 (Pubitemid 44935312)
30. L. Svennerholm, and P. Fredman A procedure for the quantitative isolation of brain gangliosides Biochim. Biophys. Acta 617 1980 97 109 (Pubitemid 10185886)
31. B. Fong, C. Norris, E. Lowe, and P. McJarrow Liquid chromatography-high- resolution mass spectrometry for quantitative analysis of gangliosides Lipids 44 2009 867 874
32. K. Ikeda, T. Shimizu, and R. Taguchi Targeted analysis of ganglioside and sulfatide molecular species by LC/ESI-MS/MS with theoretically expanded multiple reaction monitoring J. Lipid Res. 49 2008 2678 2689
33. U.S. Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, 2001.
34. X. Cai, Y. Liu, X. Zhou, U. Navaneethan, B. Shen, and B. Guo An LC-ESI-MS method for the quantitative analysis of bile acids composition in fecal materials Biomed. Chromatogr. 26 2012 101 108
35. S.F. Fernando, and B.W. Woonton Quantitation of N-acetylneuraminic (sialic) acid in bovine glycomacropeptide (GMP) J. Food Compos. Anal. 23 2010 359 366
36. B. Fong, C. Norris, and P. McJarrow Liquid chromatography-high-resolution electrostatic ion-trap mass spectrometric analysis of GD3 ganglioside in dairy products Int. Dairy J. 21 2011 42 47
37. S. McSheehy, L. Yang, R. Sturgeon, and Z. Mester Determination of methionine and selenomethionine in selenium-enriched yeast by species-specific isotope dilution with liquid chromatography-mass spectrometry and inductively coupled plasma mass spectrometry detection Anal. Chem. 77 2005 344 349 (Pubitemid 40096704)
38. A. Ćirić, H. Prosen, M. Jelikić-Stankov, and P. Crossed D signurcrossed d signević Evaluation of matrix effect in determination of some bioflavonoids in food samples by LC-MS/MS method Talanta 99 2012 780 790
39. B. Preinerstorfer, S. Schiesel, M. Lämmerhofer, and W. Lindner Metabolic profiling of intracellular metabolites in fermentation broths from β-lactam antibiotics production by liquid chromatography-tandem mass spectrometry methods J. Chromatogr. A 1217 2010 312 328
40. H.H. Bui, J.K. Leohr, and M. Kuo Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry Anal. Biochem. 423 2012 187 194